suPAR is the circulating factor in some but not all FSGS
Crossref DOI link: https://doi.org/10.1038/nrneph.2014.113-c1
Published Online: 2014-08-26
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Trachtman, Howard
Reiser, Jochen
Text and Data Mining valid from 2014-08-26
Article History
First Online: 26 August 2014
Competing interests
: H.T. declares no competing interests. J.R. is an inventor on pending and issued patents on suPAR and its modification in renal disease.